{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:01:39Z","timestamp":1790622099266,"version":"4.1.0"},"reference-count":50,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/501100007527","name":"Universit\u00e9 de Rouen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007527","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"DOI":"10.3389\/fmed.2017.00179","type":"journal-article","created":{"date-parts":[[2017,12,4]],"date-time":"2017-12-04T04:20:45Z","timestamp":1512361245000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":51,"title":["New Insights into Drug Reaction with Eosinophilia and Systemic Symptoms Pathophysiology"],"prefix":"10.3389","volume":"4","author":[{"given":"Philippe","family":"Musette","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baptiste","family":"Janela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,12,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13601-015-0073-8","article-title":"Pathogenesis and diagnosis of delayed-type drug hypersensitivity reactions, from bedside to bench and back","volume":"5","author":"Schrijvers","year":"2015","journal-title":"Clin Transl Allergy"},{"key":"B2","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/j.1365-2133.2006.07704.x","article-title":"Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?","volume":"156","author":"Kardaun","year":"2007","journal-title":"Br J Dermatol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1111\/j.1365-2133.2007.07807.x","article-title":"The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations","volume":"156","author":"Shiohara","year":"2007","journal-title":"Br J Dermatol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.amjmed.2011.01.017","article-title":"The DRESS syndrome: a literature review","volume":"124","author":"Cacoub","year":"2011","journal-title":"Am J Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.coi.2004.09.016","article-title":"Cellular mechanisms of T cell mediated drug hypersensitivity","volume":"16","author":"Gerber","year":"2004","journal-title":"Curr Opin Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.immuni.2008.04.020","article-title":"Human leukocyte antigen class I-restricted activation of CD8+ T cells provides the immunogenetic basis of a systemic drug hypersensitivity","volume":"28","author":"Chessman","year":"2008","journal-title":"Immunity"},{"key":"B7","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.tox.2003.12.008","article-title":"A chemically inert drug can stimulate T cells in vitro by their T cell receptor in non-sensitised individuals","volume":"197","author":"Engler","year":"2004","journal-title":"Toxicology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"4171","DOI":"10.1007\/s00018-010-0495-3","article-title":"T-cell recognition of chemicals, protein allergens and drugs: towards the development of in vitro assays","volume":"67","author":"Martin","year":"2010","journal-title":"Cell Mol Life Sci"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1056\/NEJMoa1013297","article-title":"HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans","volume":"364","author":"McCormack","year":"2011","journal-title":"N Engl J Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1056\/NEJMoa0706135","article-title":"HLA-B*5701 screening for hypersensitivity to abacavir","volume":"358","author":"Mallal","year":"2008","journal-title":"N Engl J Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/S0140-6736(02)07873-X","article-title":"Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir","volume":"359","author":"Mallal","year":"2002","journal-title":"Lancet"},{"key":"B12","doi-asserted-by":"publisher","first-page":"4134","DOI":"10.1073\/pnas.0409500102","article-title":"HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol","volume":"102","author":"Hung","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/S0140-6736(02)08158-8","article-title":"Genetic variations in HLA-B region and hypersensitivity reactions to abacavir","volume":"359","author":"Hetherington","year":"2002","journal-title":"Lancet"},{"key":"B14","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/428486a","article-title":"Medical genetics: a marker for Stevens-Johnson syndrome","volume":"428","author":"Chung","year":"2004","journal-title":"Nature"},{"key":"B15","doi-asserted-by":"publisher","first-page":"46ra62","DOI":"10.1126\/scitranslmed.3001116","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): a multiorgan antiviral T cell response","volume":"2","author":"Picard","year":"2010","journal-title":"Sci Transl Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1111\/j.1365-2230.2009.03718.x","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis due to anticonvulsants share certain clinical and laboratory features with drug-induced hypersensitivity syndrome, despite differences in cutaneous presentations","volume":"35","author":"Teraki","year":"2010","journal-title":"Clin Exp Dermatol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1111\/jdv.12419","article-title":"Recurrence of drug-induced reactions in DRESS patients","volume":"29","author":"Picard","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1001\/jamadermatol.2013.6698","article-title":"Prolonged evolution of drug reaction with eosinophilia and systemic symptoms: clinical, virologic, and biological features","volume":"150","author":"Tetart","year":"2014","journal-title":"JAMA Dermatol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1001\/archderm.145.1.67","article-title":"Twelve-year analysis of severe cases of drug reaction with eosinophilia and systemic symptoms: a cause of unpredictable multiorgan failure","volume":"145","author":"Eshki","year":"2009","journal-title":"Arch Dermatol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.coi.2012.07.010","article-title":"Drug reaction with eosinophilia and systemic symptoms: an update on pathogenesis","volume":"24","author":"Camous","year":"2012","journal-title":"Curr Opin Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/S0165-6147(98)01227-9","article-title":"Involvement of T cells in drug-induced allergies","volume":"19","author":"Zanni","year":"1998","journal-title":"Trends Pharmacol Sci"},{"key":"B22","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1097\/00130832-200208000-00003","article-title":"Pharmacological interaction of drugs with antigen-specific immune receptors: the P-I concept","volume":"2","author":"Pichler","year":"2002","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1038\/nature11147","article-title":"Immune self-reactivity triggered by drug-modified HLA-peptide repertoire","volume":"486","author":"Illing","year":"2012","journal-title":"Nature"},{"key":"B24","doi-asserted-by":"publisher","first-page":"9959","DOI":"10.1073\/pnas.1207934109","article-title":"Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire","volume":"109","author":"Ostrov","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1016\/j.jaci.2011.12.990","article-title":"Direct interaction between HLA-B and carbamazepine activates T cells in patients with Stevens-Johnson syndrome","volume":"129","author":"Wei","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.jaad.2012.08.009","article-title":"Long-term sequelae of drug reaction with eosinophilia and systemic symptoms: a retrospective cohort study from Taiwan","volume":"68","author":"Chen","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/1346-8138.12770","article-title":"Sequelae in 145 patients with drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms: survey conducted by the Asian Research Committee on Severe Cutaneous Adverse Reactions (ASCAR)","volume":"42","author":"Kano","year":"2015","journal-title":"J Dermatol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1056\/NEJMoa1009717","article-title":"Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan","volume":"364","author":"Chen","year":"2011","journal-title":"N Engl J Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1039\/C2FO30111C","article-title":"Modulation of amyloid-beta 1-42 structure and toxicity by proline-rich whey peptides","volume":"4","author":"Bharadwaj","year":"2013","journal-title":"Food Funct"},{"key":"B30","first-page":"301","article-title":"Association of human herpesvirus 6 infection with drug reaction with eosinophilia and systemic symptoms","volume":"137","author":"Descamps","year":"2001","journal-title":"Arch Dermatol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1111\/j.1365-2133.2006.07332.x","article-title":"Reactivation of human herpesvirus (HHV) family members other than HHV-6 in drug-induced hypersensitivity syndrome","volume":"155","author":"Seishima","year":"2006","journal-title":"Br J Dermatol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/j.1365-2133.2006.07238.x","article-title":"Several herpesviruses can reactivate in a severe drug-induced multiorgan reaction in the same sequential order as in graft-versus-host disease","volume":"155","author":"Kano","year":"2006","journal-title":"Br J Dermatol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2332\/allergolint.55.1","article-title":"Drug-induced hypersensitivity syndrome (DIHS): a reaction induced by a complex interplay among herpesviruses and antiviral and antidrug immune responses","volume":"55","author":"Shiohara","year":"2006","journal-title":"Allergol Int"},{"key":"B34","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1111\/j.1365-2133.1997.tb03795.x","article-title":"Human herpesvirus 6 infection associated with anticonvulsant hypersensitivity syndrome and reactive haemophagocytic syndrome","volume":"137","author":"Descamps","year":"1997","journal-title":"Br J Dermatol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1001\/archdermatol.2009.195","article-title":"Cytomegalovirus disease during severe drug eruptions: report of 2 cases and retrospective study of 18 patients with drug-induced hypersensitivity syndrome","volume":"145","author":"Asano","year":"2009","journal-title":"Arch Dermatol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1126\/science.2876520","article-title":"Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders","volume":"234","author":"Salahuddin","year":"1986","journal-title":"Science"},{"key":"B37","doi-asserted-by":"crossref","first-page":"8797","DOI":"10.1128\/JVI.72.11.8797-8805.1998","article-title":"CD4 promoter transactivation by human herpesvirus 6","volume":"72","author":"Flamand","year":"1998","journal-title":"J Virol"},{"key":"B38","first-page":"484","article-title":"Sequential reactivation of herpesvirus in drug-induced hypersensitivity syndrome","volume":"84","author":"Kano","year":"2004","journal-title":"Acta Derm Venereol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"206","DOI":"10.2340\/00015555-1317","article-title":"Herpes zoster in patients with drug-induced hypersensitivity syndrome\/DRESS","volume":"92","author":"Kano","year":"2012","journal-title":"Acta Derm Venereol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1001\/archdermatol.2007.48","article-title":"Toxic epidermal necrolysis due to zonisamide associated with reactivation of human herpesvirus 6","volume":"144","author":"Teraki","year":"2008","journal-title":"Arch Dermatol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1046\/j.1398-9995.2003.00336.x","article-title":"Stevens-Johnson syndrome associated with azithromycin followed by transient reactivation of herpes simplex virus infection","volume":"59","author":"Aihara","year":"2004","journal-title":"Allergy"},{"key":"B42","doi-asserted-by":"publisher","first-page":"8071","DOI":"10.4049\/jimmunol.0804002","article-title":"Defective regulatory T cells in patients with severe drug eruptions: timing of the dysfunction is associated with the pathological phenotype and outcome","volume":"182","author":"Takahashi","year":"2009","journal-title":"J Immunol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1111\/j.1348-0421.2007.tb03996.x","article-title":"Human herpesvirus 6 infection of CD4+ T-cell subsets","volume":"51","author":"Otani","year":"2007","journal-title":"Microbiol Immunol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1111\/jdv.13832","article-title":"Comparative histological analysis of drug-induced maculopapular exanthema and DRESS","volume":"30","author":"Skowron","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nri3341","article-title":"Eosinophils: changing perspectives in health and disease","volume":"13","author":"Rosenberg","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1046\/j.1365-2133.1998.02559.x","article-title":"Increased levels of interleukin 5 are associated with the generation of eosinophilia in drug-induced hypersensitivity syndrome","volume":"139","author":"Choquet-Kastylevsky","year":"1998","journal-title":"Br J Dermatol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1067\/mai.2000.110922","article-title":"Evidence for a role for IL-5 and eotaxin in activating and recruiting eosinophils in drug-induced cutaneous eruptions","volume":"106","author":"Yawalkar","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.alit.2016.06.003","article-title":"Serum TARC levels are strongly correlated with blood eosinophil count in patients with drug eruptions","volume":"66","author":"Komatsu-Fujii","year":"2017","journal-title":"Allergol Int"},{"key":"B49","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jdermsci.2012.10.002","article-title":"Identification of thymus and activation-regulated chemokine (TARC\/CCL17) as a potential marker for early indication of disease and prediction of disease activity in drug-induced hypersensitivity syndrome (DIHS)\/drug rash with eosinophilia and systemic symptoms (DRESS)","volume":"69","author":"Ogawa","year":"2013","journal-title":"J Dermatol Sci"},{"key":"B50","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.1182\/blood-2002-01-0012","article-title":"Transgenic overexpression of human IL-17E results in eosinophilia, B-lymphocyte hyperplasia, and altered antibody production","volume":"100","author":"Kim","year":"2002","journal-title":"Blood"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fmed.2017.00179\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T16:28:57Z","timestamp":1603470537000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fmed.2017.00179\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,4]]},"references-count":50,"alternative-id":["10.3389\/fmed.2017.00179"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2017.00179","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,4]]},"article-number":"179"}}